Issue link: https://www.e-digitaleditions.com/i/1491587
Inhalation February 2023 25 OINDP expertise including contract services Proveris® Laboratories offers orally inhaled and nasal drug product development (OINDP) expertise to pharmaceutical developers, including contract services employing new, innovative, in vitro techniques. ese include measuring plume front velocity and evapora- tion rate and quantifying deposition of inhaled drug products using human-realistic models. Employing in vitro approaches that are human-realistic can enable companies to make data-driven decisions and expe- dite product development and approval while saving time and resources. Learn more about these tech- niques and see data we have already published, avail- able on the Proveris website at www.proveris.com/ scientific-posters. Proveris Scientific Corporation US: +1 505 460-8822 contactus@proveris.com www.proveris.com Calibration and mensuration MSP, a Division of TSI, recognizes the need for using trustworthy and consistent inhalation test systems for drug development and QC. Without proper cleaning, calibration and mensuration, it cannot be assumed that your equipment is in compliance. MSP offers a variety of service options within USP <1058> guidelines to ensure your analytical instruments per- form within given specifications—avoiding bridging studies and saving you time and money. Keep your test equipment in compliance with regular service. MSP, a Division of TSI US: +1 651 287-8100 mspsales@tsi.com www.mspcorp.com Bespoke inhaled formulation development i2c Pharmaceutical Services is a leading independent service provider to global pharma, medical technol- ogy and emerging companies for the development of inhaled formulations and efficient devices. i2c provides bespoke integrated services from ab initio development through clinical trials. i2c also offers Respitab ® ; this propellant-dispersible tablet is a cost-effective and innovative manufacturing platform that can facilitate transition to the next generation of pressurized metered dose inhalers (pMDIs). i2c Pharmaceutical Services UK: +44 2920 757865 www.i2cpharm.co.uk Preclinical drug development Inhalation Sciences offers preclinical research ser- vices to obtain pharmacokinetic (PK) curves and dissolution data with an unprecedented level of accu- racy. is enables solid in vitro/in vivo correlations (IVIVC) and minimal translational errors, helping scientists make correct decisions about substances to send forward to clinical trials, small molecule drugs or biologics. For generic product development, Inhala- tion Sciences offers accurate dissolution profile com- parisons between test and reference substances with strong correlations to in vivo data. Inhalation Sciences Sweden: +46 70 562 5195 contact@inhalation.se www.inhalation.se